126 related articles for article (PubMed ID: 35526775)
1. Nasal secretion tissue plasminogen activator: A novel effective predictor of nasal polyp recurrence.
Chen CL; Zhao JF; Guo CL; Pan L; Ma J; Wang YT; Chen D; Kern RC; Schleimer RP; Liu Z
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2191-2194.e3. PubMed ID: 35526775
[No Abstract] [Full Text] [Related]
2. Plasminogen activators in human nasal polyps and mucosa.
Larsen K; de Maat MP; Jespersen J
Rhinology; 1997 Dec; 35(4):175-7. PubMed ID: 9532638
[TBL] [Abstract][Full Text] [Related]
3. Partial purification and characterization of the tissue plasminogen activator in nasal mucosa and nasal polyp.
Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
Biochem Med; 1985 Feb; 33(1):117-23. PubMed ID: 4039564
[TBL] [Abstract][Full Text] [Related]
4. Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes.
Chen CL; Yao Y; Pan L; Hu ST; Ma J; Wang ZC; Kern RC; Schleimer RP; Liu Z
J Allergy Clin Immunol; 2020 Sep; 146(3):677-681. PubMed ID: 32112792
[No Abstract] [Full Text] [Related]
5. [Predictive significance of tissue eosinophilia for nasal polyp recurrence].
Wang CS; Lou HF; Meng YF; Piao YS; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):268-72. PubMed ID: 27095718
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment for nasal polyposis: predictors of outcome.
Grgić MV; Ćupić H; Kalogjera L; Baudoin T
Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3735-43. PubMed ID: 25634061
[TBL] [Abstract][Full Text] [Related]
7. Basic fibroblast growth factor expression in recurrent versus non-recurrent nasal polyposis.
Cayé-Thomasen P; Larsen K; Tingsgaard P; Tos M
Eur Arch Otorhinolaryngol; 2004 Jul; 261(6):321-5. PubMed ID: 14551786
[TBL] [Abstract][Full Text] [Related]
8. Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression.
Takabayashi T; Kato A; Peters AT; Hulse KE; Suh LA; Carter R; Norton J; Grammer LC; Cho SH; Tan BK; Chandra RK; Conley DB; Kern RC; Fujieda S; Schleimer RP
Am J Respir Crit Care Med; 2013 Jan; 187(1):49-57. PubMed ID: 23155140
[TBL] [Abstract][Full Text] [Related]
9. Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population.
Lou H; Meng Y; Piao Y; Wang C; Zhang L; Bachert C
Am J Rhinol Allergy; 2015; 29(5):350-6. PubMed ID: 26219765
[TBL] [Abstract][Full Text] [Related]
10. Predictive significance of Charcot-Leyden Crystal mRNA levels in nasal brushing for nasal polyp recurrence.
Qi S; Yan B; Liu C; Wang C; Zhang L
Rhinology; 2020 Apr; 58(2):166-174. PubMed ID: 31884512
[TBL] [Abstract][Full Text] [Related]
11. Predictive Significance of Charcot-Leyden Crystal Protein in Nasal Secretions in Recurrent Chronic Rhinosinusitis with Nasal Polyps.
Wu D; Yan B; Wang Y; Zhang L; Wang C
Int Arch Allergy Immunol; 2021; 182(1):65-75. PubMed ID: 32927462
[TBL] [Abstract][Full Text] [Related]
12. The influence of nasal microbiome diversity and inflammatory patterns on the prognosis of nasal polyps.
Gan W; Zhang H; Yang F; Liu S; Liu F; Meng J
Sci Rep; 2021 Mar; 11(1):6364. PubMed ID: 33737534
[TBL] [Abstract][Full Text] [Related]
13. Presence of urokinase-type plasminogen activator (u-PA) in tissue extracts of antrochoanal polyp.
Yamashiro Y; Nakamura M; Huang GW; Kosugi T
Laryngoscope; 1992 Sep; 102(9):1049-52. PubMed ID: 1518351
[TBL] [Abstract][Full Text] [Related]
14. The development of nasal polyps involves early middle meatus mucous remodeling via TGF-β1 mediated PAI-1 reduction.
Liu Y; Shu L; Jiang X; Zhang Y; Chen Q; Shen Y; Yang Y
Braz J Otorhinolaryngol; 2023; 89(3):366-373. PubMed ID: 36841712
[TBL] [Abstract][Full Text] [Related]
15. Nasal polyps and immunoglobulin E (IgE).
Settipane GA
Allergy Asthma Proc; 1996; 17(5):269-73. PubMed ID: 8922146
[TBL] [Abstract][Full Text] [Related]
16. Decrease in number of mast cells in resected nasal polyps as an indicator for postoperative recurrence of chronic rhinosinusitis.
Teranishi Y; Jin D; Takano S; Sunami K; Takai S
Immun Inflamm Dis; 2019 Sep; 7(3):191-200. PubMed ID: 31210032
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific immunoglobulin E in human nasal polyps.
Wei CY; Fang SY
Ann Otol Rhinol Laryngol; 2005 May; 114(5):386-9. PubMed ID: 15966526
[TBL] [Abstract][Full Text] [Related]
18. [The recurrent nasal polyp analysed by mRNA difference to demonstrate].
Ni G; Chen W; Zhu Y; Zhao H
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):602-3. PubMed ID: 15620139
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid promotes fibrinolysis and may regulate polyp formation.
Sakashita M; Takabayashi T; Imoto Y; Homma T; Yoshida K; Ogi K; Kimura Y; Kato A; Stevens WW; Smith SS; Welch KC; Norton JE; Suh LA; Carter RG; Hulse KE; Seshadri S; Min JY; Pothoven KL; Conley DB; Tan BK; Harris KE; Kern RC; Haruna S; Matsuwaki Y; Ochiai R; Fujieda S; Schleimer RP
J Allergy Clin Immunol; 2022 Nov; 150(5):1114-1124.e3. PubMed ID: 35728655
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological observation of recurrent nasal polyp formation].
Chen W; Sun Q; Deng Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Feb; 32(1):15-7. PubMed ID: 10743119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
